• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Steel Partners attacks MICA poison pill

Article

The legal battle between Medical Imaging Centers of America anda dissident shareholder group continued this month when the group,Steel Partners II of New York City, filed a lawsuit to dismissMICA's poison pill defense. Steel Partners claimed that the

The legal battle between Medical Imaging Centers of America anda dissident shareholder group continued this month when the group,Steel Partners II of New York City, filed a lawsuit to dismissMICA's poison pill defense. Steel Partners claimed that the defenseis unfair to shareholders, while San Diego-based MICA respondedby stating that the lawsuit is without merit.

The legal jousting occurred as the deadline approached fora special shareholder meeting that Steel Partners called in aneffort to overthrow MICA's board (SCAN 2/14/96). That meetingwas scheduled to take place Feb. 26.

Related Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.